2015
DOI: 10.1002/cncr.29584
|View full text |Cite
|
Sign up to set email alerts
|

Prevention and management of lung cancer in China

Abstract: Lung cancer is the leading cause of cancer‐related death worldwide. In China, the incidence of lung cancer has grown rapidly, resulting in a large social and economic burden. Several researchers have devoted their studies to lung cancer and have demonstrated that there are many risk factors for lung cancer in China, including tobacco use, environmental pollution, food, genetics, and chronic obstructive pulmonary disease. However, the lung cancer incidence is still growing rapidly in China, and there is an even… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
186
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 221 publications
(187 citation statements)
references
References 18 publications
0
186
0
1
Order By: Relevance
“…Lung cancer is the leading cause of cancer death worldwide, especially in China [1, 2]. Though multimodal therapies are often used in patients with non-small cell lung cancer (NSCLC), the overall prognosis of NSCLC remains poor [3].…”
Section: Introductionmentioning
confidence: 99%
“…Lung cancer is the leading cause of cancer death worldwide, especially in China [1, 2]. Though multimodal therapies are often used in patients with non-small cell lung cancer (NSCLC), the overall prognosis of NSCLC remains poor [3].…”
Section: Introductionmentioning
confidence: 99%
“…According to the World Cancer Report 2014 issued by the World Health Organization (WHO), the incidence rate and mortality rate of lung cancer have boosted in the world, and rank first in all malignant tumors [1]. Among all types of lung cancers, Non-Small Cell Lung Cancer (NSCLC) occupies almost 80%, but the 5 y survival rate is only 13% [2,3].…”
Section: Introductionmentioning
confidence: 99%
“…Lung cancer, particularly non-small cell lung cancer (NSCLC), remains a challenging disease with high mortality worldwide [1-2]. Despite the tremendous mountainous progress in multidisciplinary therapy, the overall 5-year survival rate is still poor [3].…”
Section: Introductionmentioning
confidence: 99%